General Information of Drug (ID: DM450XS)

Drug Name
BAY 2253651 Drug Info
Indication
Disease Entry ICD 11 Status REF
Obstructive sleep apnea 7A41 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM450XS

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BAY-2253651 DMM7Q68 Obstructive sleep apnea 7A41 Phase 2 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
TWIK-related acid-sensitive potassium channel 1 (TASK1) TTGR91N KCNK3_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT03603678) Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor (SANDMAN). U.S. National Institutes of Health.
2 Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.